Free Trial

Cytosorbents (CTSO) Competitors

Cytosorbents logo
$1.03 -0.03 (-2.83%)
Closing price 03/3/2025 04:00 PM Eastern
Extended Trading
$1.02 -0.01 (-0.49%)
As of 03/3/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CTSO vs. ZYXI, INGN, ELMD, PROF, LAKE, NVRO, SKIN, DRTS, CATX, and BWAY

Should you be buying Cytosorbents stock or one of its competitors? The main competitors of Cytosorbents include Zynex (ZYXI), Inogen (INGN), Electromed (ELMD), Profound Medical (PROF), Lakeland Industries (LAKE), Nevro (NVRO), Beauty Health (SKIN), Alpha Tau Medical (DRTS), Perspective Therapeutics (CATX), and BrainsWay (BWAY). These companies are all part of the "medical equipment" industry.

Cytosorbents vs.

Zynex (NASDAQ:ZYXI) and Cytosorbents (NASDAQ:CTSO) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, community ranking, profitability, risk, media sentiment, earnings and valuation.

29.7% of Zynex shares are held by institutional investors. Comparatively, 32.9% of Cytosorbents shares are held by institutional investors. 52.1% of Zynex shares are held by insiders. Comparatively, 6.6% of Cytosorbents shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Zynex has a net margin of 2.49% compared to Cytosorbents' net margin of -49.47%. Zynex's return on equity of 13.05% beat Cytosorbents' return on equity.

Company Net Margins Return on Equity Return on Assets
Zynex2.49% 13.05% 3.78%
Cytosorbents -49.47%-118.54%-42.31%

Cytosorbents received 411 more outperform votes than Zynex when rated by MarketBeat users. Likewise, 74.20% of users gave Cytosorbents an outperform vote while only 58.00% of users gave Zynex an outperform vote.

CompanyUnderperformOutperform
ZynexOutperform Votes
29
58.00%
Underperform Votes
21
42.00%
CytosorbentsOutperform Votes
440
74.20%
Underperform Votes
153
25.80%

Zynex has a beta of 0.54, meaning that its stock price is 46% less volatile than the S&P 500. Comparatively, Cytosorbents has a beta of 0.61, meaning that its stock price is 39% less volatile than the S&P 500.

Zynex presently has a consensus price target of $14.00, indicating a potential upside of 94.17%. Cytosorbents has a consensus price target of $4.67, indicating a potential upside of 353.07%. Given Cytosorbents' higher probable upside, analysts clearly believe Cytosorbents is more favorable than Zynex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zynex
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Cytosorbents
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.00

Zynex has higher revenue and earnings than Cytosorbents. Cytosorbents is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zynex$193.67M1.19$9.73M$0.1548.07
Cytosorbents$33.79M1.67-$28.51M-$0.36-2.86

In the previous week, Cytosorbents had 5 more articles in the media than Zynex. MarketBeat recorded 9 mentions for Cytosorbents and 4 mentions for Zynex. Zynex's average media sentiment score of 0.91 beat Cytosorbents' score of 0.44 indicating that Zynex is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Zynex
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cytosorbents
0 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Zynex beats Cytosorbents on 9 of the 17 factors compared between the two stocks.

Get Cytosorbents News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CTSO vs. The Competition

MetricCytosorbentsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$56.32M$4.58B$5.81B$8.39B
Dividend YieldN/A36.92%4.75%3.98%
P/E Ratio-2.8630.3924.9519.25
Price / Sales1.6750.34375.54110.22
Price / CashN/A51.0838.0534.58
Price / Book1.986.267.334.28
Net Income-$28.51M$67.64M$3.18B$247.04M
7 Day Performance-5.50%-4.85%-2.89%-3.25%
1 Month Performance4.22%-9.15%-6.79%-6.55%
1 Year Performance8.42%10.84%12.28%4.01%

Cytosorbents Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CTSO
Cytosorbents
2.2248 of 5 stars
$1.03
-2.8%
$4.67
+353.1%
+8.6%$56.32M$33.79M-2.86220Upcoming Earnings
Analyst Forecast
Gap Up
ZYXI
Zynex
3.4414 of 5 stars
$7.36
+2.4%
$14.00
+90.2%
-41.4%$234.42M$184.32M49.071,100
INGN
Inogen
3.3635 of 5 stars
$9.84
-0.7%
$7.00
-28.9%
+15.7%$234.37M$331.52M-4.371,030Short Interest ↓
ELMD
Electromed
0.8305 of 5 stars
$26.97
-3.6%
$38.00
+40.9%
+70.6%$230.78M$59.63M35.96160
PROF
Profound Medical
2.1844 of 5 stars
$7.44
-0.5%
$14.25
+91.5%
-23.8%$223.50M$7.20M-5.55150Positive News
LAKE
Lakeland Industries
4.6707 of 5 stars
$23.50
-4.9%
$27.50
+17.0%
+33.6%$223.23M$151.82M-261.111,750Short Interest ↑
NVRO
Nevro
2.5133 of 5 stars
$5.73
-0.1%
$6.43
+12.2%
-59.7%$214.53M$419.15M-3.031,215Upcoming Earnings
Short Interest ↓
SKIN
Beauty Health
1.7259 of 5 stars
$1.56
-3.1%
$2.55
+63.5%
-65.8%$193.63M$398M-3.711,030Upcoming Earnings
DRTS
Alpha Tau Medical
2.797 of 5 stars
$2.74
+2.2%
$8.00
+192.0%
-3.0%$191.58MN/A-6.3780Positive News
CATX
Perspective Therapeutics
1.8147 of 5 stars
$2.73
-1.1%
$15.14
+454.7%
N/A$184.52M$1.43M0.0070
BWAY
BrainsWay
3.0027 of 5 stars
$9.78
-9.0%
$13.17
+34.6%
+42.4%$184.02M$38.63M97.81120Short Interest ↑
Gap Up
High Trading Volume

Related Companies and Tools


This page (NASDAQ:CTSO) was last updated on 3/4/2025 by MarketBeat.com Staff
From Our Partners